Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision history updated to show v3.4.2 added and v3.4.1 removed.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded a new revision entry v3.4.1 to the study history. Removed the previous revision v3.4.0.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page history now shows a new revision v3.3.4 and removes v3.3.3 from the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedA new revision note (v3.3.3) was added and an older revision note (v3.3.2) plus the HHS Vulnerability Disclosure link were removed. These changes reflect administrative footer updates.SummaryDifference0.1%

- Check91 days agoChange DetectedSite version updated from v3.2.0 to v3.3.2; no visible changes to trial data or the Record History page.SummaryDifference0.0%

- Check99 days agoChange DetectedNotice about a government funding lapse was removed from the page. This is an operational update and does not affect the trial data or history content.SummaryDifference0.3%

Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.